Antihypertensive Agents

"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Descriptor ID	D000959
MeSH Number(s)	D27.505.954.411.162
Concept/Terms	Antihypertensive Agents Antihypertensive Agents Agents, Antihypertensive Antihypertensives Anti-Hypertensives Anti Hypertensives Antihypertensive Drugs Drugs, Antihypertensive Anti-Hypertensive Agents Agents, Anti-Hypertensive Anti Hypertensive Agents Anti-Hypertensive Drugs Anti Hypertensive Drugs Drugs, Anti-Hypertensive

Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Antihypertensive Agents [D27.505.954.411.162]

Below are MeSH descriptors whose meaning is related to "Antihypertensive Agents".

Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.

Bar chart showing 260 publications over 28 distinct years, with a maximum of 20 publications in 2006 and 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1998	2	0	2
1999	6	0	6
2000	3	1	4
2001	10	1	11
2002	5	5	10
2003	10	7	17
2004	7	3	10
2005	11	4	15
2006	12	8	20
2007	7	6	13
2008	13	7	20
2009	2	5	7
2010	5	2	7
2011	5	4	9
2012	2	2	4
2013	2	3	5
2014	8	3	11
2015	3	4	7
2016	4	5	9
2017	4	2	6
2018	9	7	16
2019	4	6	10
2020	9	1	10
2021	5	2	7
2022	2	6	8
2023	0	5	5
2024	4	6	10

Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.

Soltani G, Shalaby WS, Razeghinejad R. Latanoprostene bunod: the first nitric oxide-donating antiglaucoma medication. Med Gas Res. 2025 Jun 01; 15(2):220-227.

View in: PubMed
King JB, Sakhuja S, Derington CG, Kolm P, Herrick JS, Berchie RO, Shen J, Greene T, Tajeu GS, Howard G, Levitan EB, Muntner P, Safford MM, Ying J, Weintraub WS, Moran AE, Bress AP, Bellows BK. Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States. J Am Heart Assoc. 2024 09 17; 13(18):e034515.

View in: PubMed
Cooper LA, Marsteller JA, Carson KA, Dietz KB, Boonyasai RT, Alvarez C, Crews DC, Dennison Himmelfarb CR, Ibe CA, Lubomski L, Miller ER, Wang NY, Avornu GD, Brown D, Hickman D, Simmons M, Apfel Stein A, Yeh HC. Equitable Care for Hypertension: Blood Pressure and Patient-Reported Outcomes of the RICH LIFE Cluster Randomized Trial. Circulation. 2024 Jul 16; 150(3):230-242.

View in: PubMed
Arshed M, Mahmud A, Minhat HS, Lim PY, Zakar R. Effectiveness of a Multifaceted Mobile Health Intervention (Multi-Aid-Package) in Medication Adherence and Treatment Outcomes Among Patients With Hypertension in a Low- to Middle-Income Country: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2024 06 19; 12:e50248.

View in: PubMed
Rhee DJ, Sancheti H, Rothman AL, Herndon L, Brubaker JW, Patrianakos T, Radcliffe N, Zhang AD, Szczotka-Flynn L. Primary Practice Patterns for the Initial Management of Open Angle Glaucoma. J Glaucoma. 2024 09 01; 33(9):671-678.

View in: PubMed
Moore MD, Kuo HC, Sinkey RG, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson KS, Haas DM, Plante L, Metz TD, Casey B, Esplin S, Longo S, Hoffman MK, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey HA, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su EJ, Krishna I, Nguyen NA, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Librizzi R, Pereira L, Magann EF, Habli M, Williams S, Mari G, Pridjian G, McKenna DS, Parrish M, Chang E, Osmundson S, Qui?ones JN, Leach J, Sanusi A, Galis ZS, Harper L, Ambalavanan N, Szychowski JM, Tita ATN. Mean Arterial Pressure and Neonatal Outcomes in Pregnancies Complicated by Mild Chronic Hypertension. Obstet Gynecol. 2024 07 01; 144(1):101-108.

View in: PubMed
Sanusi AA, Leach J, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson KS, Haas DM, Plante L, Metz TD, Casey B, Esplin S, Longo S, Hoffman MK, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Su EJ, Krishna I, Nguyen NA, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Geller NL, Kuo HC, Sinkey RG, Librizzi R, Pereira L, Magann EF, Habli M, Williams S, Mari G, Pridjian G, McKenna DS, Parrish M, Osmundson S, Quinones J, Szychowski JM, Tita ATN. Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024 07 01; 144(1):126-134.

View in: PubMed
Leshno A, Bommakanti N, De Moraes CG, Gordon MO, Kass MA, Cioffi GA, Liebmann JM. Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc. Eye (Lond). 2024 Jun; 38(8):1549-1555.

View in: PubMed
Zhang F, Bryant KB, Moran AE, Zhang Y, Cohen JB, Bress AP, Sheppard JP, King JB, Derington CG, Weintraub WS, Kronish IM, Shea S, Bellows BK. Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A?Simulation Study. J Am Heart Assoc. 2024 01 16; 13(2):e032370.

View in: PubMed
Kelly MS, Dacey A, Siana A, Ojeda J. Efficacy and Safety of a Polypill to Reduce Cardiovascular Events: A Review of Clinical Trials. J Cardiovasc Pharmacol. 2024 01 01; 83(1):8-15.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement